975 related articles for article (PubMed ID: 16322344)
1. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
3. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
Dorgan JF; Longcope C; Stephenson HE; Falk RT; Miller R; Franz C; Kahle L; Campbell WS; Tangrea JA; Schatzkin A
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):533-9. PubMed ID: 8827358
[TBL] [Abstract][Full Text] [Related]
4. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
5. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
Dorgan JF; Stanczyk FZ; Longcope C; Stephenson HE; Chang L; Miller R; Franz C; Falk RT; Kahle L
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
[TBL] [Abstract][Full Text] [Related]
6. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
7. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
8. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition.
Baglietto L; English DR; Hopper JL; MacInnis RJ; Morris HA; Tilley WD; Krishnan K; Giles GG
Breast Cancer Res Treat; 2009 May; 115(1):171-9. PubMed ID: 18509757
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
Schairer C; Hill D; Sturgeon SR; Fears T; Mies C; Ziegler RG; Hoover RN; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1660-5. PubMed ID: 16030098
[TBL] [Abstract][Full Text] [Related]
10. Serum sex hormones and breast cancer risk factors in postmenopausal women.
Lamar CA; Dorgan JF; Longcope C; Stanczyk FZ; Falk RT; Stephenson HE
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):380-3. PubMed ID: 12692114
[TBL] [Abstract][Full Text] [Related]
11. C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Bezemer ID; Rinaldi S; Dossus L; Gils CH; Peeters PH; Noord PA; Bueno-de-Mesquita HB; Johnsen SP; Overvad K; Olsen A; Tjønneland A; Boeing H; Lahmann PH; Linseisen J; Nagel G; Allen N; Roddam A; Bingham S; Khaw KT; Kesse E; Téhard B; Clavel-Chapelon F; Agudo A; Ardanaz E; Quiros JR; Amiano P; Martínez-Garcia C; Tormo MJ; Pala V; Panico S; Vineis P; Palli D; Tumino R; Trichopoulou A; Baibas N; Zilis D; Hémon B; Norat T; Riboli E; Kaaks R
Cancer Causes Control; 2005 Jun; 16(5):561-72. PubMed ID: 15986111
[TBL] [Abstract][Full Text] [Related]
12. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort.
Verheus M; Peeters PH; van Noord PA; van der Schouw YT; Grobbee DE; van Gils CH
Breast Cancer Res; 2007; 9(4):R53. PubMed ID: 17692133
[TBL] [Abstract][Full Text] [Related]
13. Urinary cadmium and serum levels of estrogens and androgens in postmenopausal Japanese women.
Nagata C; Nagao Y; Shibuya C; Kashiki Y; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):705-8. PubMed ID: 15767353
[TBL] [Abstract][Full Text] [Related]
14. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
15. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics.
Dai Q; Franke AA; Yu H; Shu XO; Jin F; Hebert JR; Custer LJ; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):497-502. PubMed ID: 12814993
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone levels and risk of cardiovascular events in postmenopausal women.
Rexrode KM; Manson JE; Lee IM; Ridker PM; Sluss PM; Cook NR; Buring JE
Circulation; 2003 Oct; 108(14):1688-93. PubMed ID: 12975257
[TBL] [Abstract][Full Text] [Related]
17. Does androgen excess contribute to the cardiovascular risk profile in postmenopausal women with type 2 diabetes?
Korytkowski MT; Krug EI; Daly MA; Deriso L; Wilson JW; Winters SJ
Metabolism; 2005 Dec; 54(12):1626-31. PubMed ID: 16311096
[TBL] [Abstract][Full Text] [Related]
18. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
19. Serum and urinary androgens and risk of breast cancer in postmenopausal women.
Secreto G; Toniolo P; Berrino F; Recchione C; Cavalleri A; Pisani P; Totis A; Fariselli G; Di Pietro S
Cancer Res; 1991 May; 51(10):2572-6. PubMed ID: 2021938
[TBL] [Abstract][Full Text] [Related]
20. Relation of BMI and physical activity to sex hormones in postmenopausal women.
McTiernan A; Wu L; Chen C; Chlebowski R; Mossavar-Rahmani Y; Modugno F; Perri MG; Stanczyk FZ; Van Horn L; Wang CY;
Obesity (Silver Spring); 2006 Sep; 14(9):1662-77. PubMed ID: 17030978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]